Recently, a multiomics analysis study on the treatment of diabetic nephropathy carried out by the Nephrology Team of the Children's Hospital Affiliated to Zhejiang University School of Medicine in collaboration with Wanbangde Pharmaceutical Group Co., Ltd. published the latest research results. The study showed promising therapeutic efficacy in reducing diabetes-induced kidney damage, lipid metabolism disorder, and inflammation. The study was published in the journal PharmacologicalResearch.

Zhitongcaijing · 10/18 02:49
Recently, a multiomics analysis study on the treatment of diabetic nephropathy carried out by the Nephrology Team of the Children's Hospital Affiliated to Zhejiang University School of Medicine in collaboration with Wanbangde Pharmaceutical Group Co., Ltd. published the latest research results. The study showed promising therapeutic efficacy in reducing diabetes-induced kidney damage, lipid metabolism disorder, and inflammation. The study was published in the journal PharmacologicalResearch.